ClinGen Dosage Sensitivity Curation Page

See New Dosage Map New! The ClinGen Dosage Sensitivity curations and downloads that are available at this site are now also available at www.clinicalgenome.org. Click on the button to access Dosage Sensitivity in the context of ClinGen's other curated information, including Gene-Disease Validity and Clinical Actionability.

DLK1

  • Curation Status: Complete

Location Information

  • 14q32.2
  • GRCh37/hg19 chr14: 101,193,202-101,204,561
  • View: NCBI | Ensembl | UCSC
  • GRCh38/hg38 chr14: 100,726,892-100,738,224
  • View: NCBI | Ensembl | UCSC
Select assembly: (NC_000014.8) (NC_000014.9)
  • Haploinsufficiency score: 0
  • Strength of Evidence (disclaimer): No evidence for dosage pathogenicity

Haploinsufficiency phenotype comments:

There are no reports in the literature of focal deletions or loss of function mutations involving DLK1. There have been a number of families and sporadic cases with upd(14)pat or upd(14)mat-like phenotypes and larger deletions that include DLK1 and other genes within this imprinted region (PMIDs: 18176563, 20179077, 18454453). The possibility of loss of paternal expression of DLK1 as the mechanism for the upd(14)mat phenotype has been discussed (PMID: 18698157) but has not been proven.

  • Triplosensitivity score: 0
  • Strength of Evidence (disclaimer): No evidence for dosage pathogenicity